Bio-Gene Technology (ASX:BGT) Net Margin %: 0.00% (As of Dec. 2025)


What is Bio-Gene Technology Net Margin %?

Bio-Gene Technology ASX:BGT Net Margin % is 0.00% as of Dec. 2025. The stock has 2 warning signs investors should review. Among 947 Biotechnology companies, Bio-Gene Technology ranks worse than 105596.52% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Bio-Gene Technology's Net Income for the six months ended in Dec. 2025 was A$-1.40 Mil. Bio-Gene Technology's Revenue for the six months ended in Dec. 2025 was A$0.00 Mil. Therefore, Bio-Gene Technology's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Bio-Gene Technology's Net Margin % or its related term are showing as below:


ASX:BGT's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.56
* Ranked among companies with meaningful Net Margin % only.

Bio-Gene Technology  (ASX:BGT) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Bio-Gene Technology Net Margin % Related Terms

Bio-Gene Technology Net Margin % Historical Data

* Premium members only.

The historical data trend for Bio-Gene Technology's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Gene Technology Net Margin % Chart

Bio-Gene Technology Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Net Margin %
Get a 7-Day Free Trial -418.15 -331.14 -520.34 0.00 0.00

Bio-Gene Technology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7,942.11 0.00 0.00 0.00 0.00

ASX:BGT vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Bio-Gene Technology's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Gene Technology Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Gene Technology's Net Margin % distribution charts can be found below:

* The bar in red indicates where Bio-Gene Technology's Net Margin % falls into.


Bio-Gene Technology Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Bio-Gene Technology's Net Margin for the fiscal year that ended in Jun. 2025 is calculated as

Net Margin=Net Income (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-2.584/0
= %

Bio-Gene Technology's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.401/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Bio-Gene Technology (ASX:BGT) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Bio-Gene Technology and its competitors. According to the industry distribution chart, Bio-Gene Technology ranks #999999 out of 947 companies in the Biotechnology industry.
Is Bio-Gene Technology's Net Margin % too high?
Bio-Gene Technology's current Net Margin % is 0.00%. Based on the distribution chart, Bio-Gene Technology ranks #999999 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Bio-Gene Technology's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bio-Gene Technology ranks #999999 out of 947 companies for Net Margin %. This places Bio-Gene Technology in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Bio-Gene Technology and its competitors. Bio-Gene Technology's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Gene Technology stock overvalued right now?
Bio-Gene Technology (ASX:BGT) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Bio-Gene Technology (ASX:BGT), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Gene Technology Business Description

Address 400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000
Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance and toxicity. Its products are based on a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. Bio-Gene's products have multiple applications across public health, crop protection, grain storage, and consumer use. The company operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.